Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| GE HealthCare Technologies Inc.GEHC · Entity 1711 | CEO, Imaging | March 02, 2026 | March 04, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
GE HealthCare Technologies Inc.
Report date March 02, 2026 · Filed March 04, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, par value $0.01 per shareSEC Table I · non-derivative | Direct | 41,082 |
Reported balance
After 2026-03-02 transaction · row 1
1 source rowRow 1 · 2026-03-02 · Grant · Acquired 8,576 · Balance 41,082 F1: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare Technologies Inc. ("GE HealthCare") common stock. F2: Award of restricted stock units with respect to GE HealthCare common stock, of which 33% will vest on September 2, 2027, 33% will vest on September 2, 2028, and 34% will vest on September 2, 2029. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $80.16 · Expires 2036-03-02 | Direct | 22,548 |
Reported balance
After 2026-03-02 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-03-02 · Grant · Acquired 22,548 · Balance 22,548 F3: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 2, 2027, 33% will become exercisable on September 2, 2028, and 34% will become exercisable on September 2, 2029. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare Technologies Inc. ("GE HealthCare") common stock.
F2: Award of restricted stock units with respect to GE HealthCare common stock, of which 33% will vest on September 2, 2027, 33% will vest on September 2, 2028, and 34% will vest on September 2, 2029.
F3: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 2, 2027, 33% will become exercisable on September 2, 2028, and 34% will become exercisable on September 2, 2029.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 02, 2026 Filed Mar 4, 2026 21:23 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantEmployee Stock Option (right to buy) · Derivative | 22,548 | $0.00 Strike: $80.16 | $0.00 |
DisclosureSEC source: 0001952159-26-000006 · wk-form4_1772659420.xml · derivative · entry 2 Rott Roland · CIK 0001952159 · CEO, Imaging 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,548 Underlying: Common Stock, par value $0.01 per share · 22,548 shares Expires 2036-03-02 F3 · price: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 2, 2027, 33% will become exercisable on September 2, 2028, and 34% will become exercisable on September 2, 2029. F3 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 2, 2027, 33% will become exercisable on September 2, 2028, and 34% will become exercisable on September 2, 2029. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 21:23 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantCommon Stock, par value $0.01 per share | 8,576 | $0.00 | $0.00 |
DisclosureSEC source: 0001952159-26-000006 · wk-form4_1772659420.xml · nonDerivative · entry 1 Rott Roland · CIK 0001952159 · CEO, Imaging 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,082 F1 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare Technologies Inc. ("GE HealthCare") common stock. F2 · shares: Award of restricted stock units with respect to GE HealthCare common stock, of which 33% will vest on September 2, 2027, 33% will vest on September 2, 2028, and 34% will vest on September 2, 2029. Read SEC document |
| February 12, 2026 Filed Feb 18, 2026 00:16 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | Tax withholdingCommon Stock, par value $0.01 per share | 3,943 | $79.20 | $312,285.60 |
DisclosureSEC source: 0001952159-26-000004 · wk-form4_1771373792.xml · nonDerivative · entry 2 Rott Roland · CIK 0001952159 · CEO, Imaging 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,506 F2 · shares: Withholding of shares of GE HealthCare common stock to satisfy tax withholding obligations in connection with the vesting of PSUs. Read SEC document |
| February 12, 2026 Filed Feb 18, 2026 00:16 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantCommon Stock, par value $0.01 per share | 7,885 | $0.00 | $0.00 |
DisclosureSEC source: 0001952159-26-000004 · wk-form4_1771373792.xml · nonDerivative · entry 1 Rott Roland · CIK 0001952159 · CEO, Imaging 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,449 F1 · shares: Performance stock units ("PSUs") granted on March 1, 2023, by GE HealthCare Technologies Inc. ("GE HealthCare"). Each PSU represented the right to receive one share of GE HealthCare common stock. The applicable performance criteria were satisfied and certified by GE HealthCare's Talent, Culture, and Compensation Committee and the PSUs vested on February 12, 2026. Read SEC document |
| February 01, 2026 Filed Feb 3, 2026 23:56 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | Tax withholdingCommon Stock, par value $0.01 per share | 558 | $78.97 | $44,065.26 |
DisclosureSEC source: 0001952159-26-000002 · wk-form4_1770162996.xml · nonDerivative · entry 1 Rott Roland · CIK 0001952159 · CEO, Imaging 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,564 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| September 11, 2025 Filed Sep 12, 2025 20:05 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,614 | $0.00 Strike: $51.67 | $0.00 |
DisclosureSEC source: 0001952159-25-000008 · wk-form4_1757707503.xml · derivative · entry 6 Rott Roland · CIK 0001952159 · CEO, Imaging 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, par value $0.01 per share · 1,614 shares Expires 2029-04-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by General Electric Company ("GE") as a result of the consummation on January 3, 2023, of the distribution of approximately 80.1% of the shares of GE HealthCare common stock by GE to holders of GE common stock on a pro-rata basis, of which 100% was fully exercisable immediately. Read SEC document |
| September 11, 2025 Filed Sep 12, 2025 20:05 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 3,727 | $0.00 Strike: $57.74 | $0.00 |
DisclosureSEC source: 0001952159-25-000008 · wk-form4_1757707503.xml · derivative · entry 5 Rott Roland · CIK 0001952159 · CEO, Imaging 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, par value $0.01 per share · 3,727 shares Expires 2029-03-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by General Electric Company ("GE") as a result of the consummation on January 3, 2023, of the distribution of approximately 80.1% of the shares of GE HealthCare common stock by GE to holders of GE common stock on a pro-rata basis, of which 100% was fully exercisable immediately. Read SEC document |
| September 11, 2025 Filed Sep 12, 2025 20:05 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | Tax withholdingCommon Stock, par value $0.01 per share | 1,352 | $76.68 | $103,671.36 |
DisclosureSEC source: 0001952159-25-000008 · wk-form4_1757707503.xml · nonDerivative · entry 4 Rott Roland · CIK 0001952159 · CEO, Imaging 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,122 F1 · shares: Represents the number of shares withheld by GE HealthCare Technologies Inc. ("GE HealthCare") to satisfy the exercise price and tax withholding obligations in connection with the net settlement of the options, and does not represent a sale of any shares by the Reporting Person. Read SEC document |
| September 11, 2025 Filed Sep 12, 2025 20:05 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | Exercise / conversionCommon Stock, par value $0.01 per share | 1,614 | $51.67 | $83,395.38 |
DisclosureSEC source: 0001952159-25-000008 · wk-form4_1757707503.xml · nonDerivative · entry 3 Rott Roland · CIK 0001952159 · CEO, Imaging 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,474 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 11, 2025 Filed Sep 12, 2025 20:05 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | Tax withholdingCommon Stock, par value $0.01 per share | 3,268 | $76.68 | $250,590.24 |
DisclosureSEC source: 0001952159-25-000008 · wk-form4_1757707503.xml · nonDerivative · entry 2 Rott Roland · CIK 0001952159 · CEO, Imaging 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,860 F1 · shares: Represents the number of shares withheld by GE HealthCare Technologies Inc. ("GE HealthCare") to satisfy the exercise price and tax withholding obligations in connection with the net settlement of the options, and does not represent a sale of any shares by the Reporting Person. Read SEC document |
| September 11, 2025 Filed Sep 12, 2025 20:05 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | Exercise / conversionCommon Stock, par value $0.01 per share | 3,727 | $57.74 | $215,196.98 |
DisclosureSEC source: 0001952159-25-000008 · wk-form4_1757707503.xml · nonDerivative · entry 1 Rott Roland · CIK 0001952159 · CEO, Imaging 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,128 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 01, 2025 Filed Sep 3, 2025 20:15 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | Tax withholdingCommon Stock, par value $0.01 per share | 459 | $73.73 | $33,842.07 |
DisclosureSEC source: 0001952159-25-000006 · wk-form4_1756930522.xml · nonDerivative · entry 3 Rott Roland · CIK 0001952159 · CEO, Imaging 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,401 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| September 01, 2025 Filed Sep 3, 2025 20:15 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | Tax withholdingCommon Stock, par value $0.01 per share | 690 | $73.73 | $50,873.70 |
DisclosureSEC source: 0001952159-25-000006 · wk-form4_1756930522.xml · nonDerivative · entry 2 Rott Roland · CIK 0001952159 · CEO, Imaging 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,860 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| September 01, 2025 Filed Sep 3, 2025 20:15 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | Tax withholdingCommon Stock, par value $0.01 per share | 685 | $73.73 | $50,505.05 |
DisclosureSEC source: 0001952159-25-000006 · wk-form4_1756930522.xml · nonDerivative · entry 1 Rott Roland · CIK 0001952159 · CEO, Imaging 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,550 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| March 03, 2025 Filed Mar 6, 2025 00:36 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantEmployee Stock Option (right to buy) · Derivative | 22,742 | $0.00 Strike: $86.45 | $0.00 |
DisclosureSEC source: 0001628280-25-010698 · wk-form4_1741221394.xml · derivative · entry 2 Rott Roland · CIK 0001952159 · CEO, Imaging 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,742 Underlying: Common Stock, par value $0.01 per share · 22,742 shares Expires 2035-03-03 F3 · price: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 3, 2026, 33% will become exercisable on September 3, 2027, and 34% will become exercisable on September 3, 2028, subject to certain conditions. F3 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 3, 2026, 33% will become exercisable on September 3, 2027, and 34% will become exercisable on September 3, 2028, subject to certain conditions. Read SEC document |
| March 03, 2025 Filed Mar 6, 2025 00:36 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantCommon Stock, par value $0.01 per share | 7,952 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-010698 · wk-form4_1741221394.xml · nonDerivative · entry 1 Rott Roland · CIK 0001952159 · CEO, Imaging 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,235 F1 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare Technologies Inc. ("GE HealthCare") common stock. F2 · shares: Award of restricted stock units with respect to GE HealthCare common stock, of which 33% will vest on September 3, 2026, 33% will vest on September 3, 2027, and 34% will vest on September 3, 2028. Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 22:27 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | Tax withholdingCommon Stock, par value $0.01 per share | 1,457 | $87.35 | $127,268.95 |
DisclosureSEC source: 0001628280-25-009982 · wk-form4_1741127247.xml · nonDerivative · entry 1 Rott Roland · CIK 0001952159 · CEO, Imaging 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,283 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| February 01, 2025 Filed Feb 4, 2025 21:24 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | Tax withholdingCommon Stock, par value $0.01 per share | 558 | $88.30 | $49,271.40 |
DisclosureSEC source: 0001628280-25-003741 · wk-form4_1738704260.xml · nonDerivative · entry 1 Rott Roland · CIK 0001952159 · CEO, Imaging 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,740 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| November 06, 2024 Filed Nov 6, 2024 22:53 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | SaleCommon Stock, par value $0.01 per share | 3,577 | $86.48 | $309,338.96 |
DisclosureSEC source: 0001628280-24-045853 · wk-form4_1730933576.xml · nonDerivative · entry 3 Rott Roland · CIK 0001952159 · CEO, Imaging 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,298 F2 · price: The price reported represents the weighted average price of shares sold. These shares were sold in multiple transactions at prices ranging from $86.48 to $86.54, inclusive. The Reporting Person undertakes to provide to GE HealthCare, any security holder of GE HealthCare, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2). Read SEC document |
| November 05, 2024 Filed Nov 6, 2024 22:53 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 13,275 | $0.00 Strike: $40.40 | $0.00 |
DisclosureSEC source: 0001628280-24-045853 · wk-form4_1730933576.xml · derivative · entry 4 Rott Roland · CIK 0001952159 · CEO, Imaging 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, par value $0.01 per share · 13,275 shares Expires 2028-12-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by General Electric Company ("GE") as a result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of GE HealthCare common stock by GE to holders of GE common stock on a pro-rata basis, of which 100% was fully exercisable immediately. Read SEC document |
| November 05, 2024 Filed Nov 6, 2024 22:53 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | Tax withholdingCommon Stock, par value $0.01 per share | 9,698 | $87.65 | $850,029.70 |
DisclosureSEC source: 0001628280-24-045853 · wk-form4_1730933576.xml · nonDerivative · entry 2 Rott Roland · CIK 0001952159 · CEO, Imaging 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,875 F1 · shares: Represents the number of shares withheld by GE HealthCare Technologies Inc. ("GE HealthCare") to satisfy the exercise price and tax withholding obligations in connection with the net settlement of the options, and does not represent a sale of any shares by the Reporting Person. Read SEC document |
| November 05, 2024 Filed Nov 6, 2024 22:53 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | Exercise / conversionCommon Stock, par value $0.01 per share | 13,275 | $40.40 | $536,310.00 |
DisclosureSEC source: 0001628280-24-045853 · wk-form4_1730933576.xml · nonDerivative · entry 1 Rott Roland · CIK 0001952159 · CEO, Imaging 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,573 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 01, 2024 Filed Sep 4, 2024 20:06 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | Tax withholdingCommon Stock, par value $0.01 per share | 685 | $84.82 | $58,101.70 |
DisclosureSEC source: 0001628280-24-039303 · wk-form4_1725480407.xml · nonDerivative · entry 1 Rott Roland · CIK 0001952159 · CEO, Imaging 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,298 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| August 15, 2024 Filed Aug 19, 2024 20:16 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantEmployee Stock Option (right to buy) · Derivative | 8,419 | $0.00 Strike: $85.30 | $0.00 |
DisclosureSEC source: 0001628280-24-037703 · wk-form4_1724098568.xml · derivative · entry 2 Rott Roland · CIK 0001952159 · CEO, Imaging 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,419 Underlying: Common Stock, par value $0.01 per share · 8,419 shares Expires 2034-08-15 F3 · price: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 1 2025, 33% will become exercisable on September 1, 2026, and 34% will become exercisable on September 1, 2027, subject to certain conditions. F3 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 1 2025, 33% will become exercisable on September 1, 2026, and 34% will become exercisable on September 1, 2027, subject to certain conditions. Read SEC document |
| August 15, 2024 Filed Aug 19, 2024 20:16 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantCommon Stock, par value $0.01 per share | 2,784 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-037703 · wk-form4_1724098568.xml · nonDerivative · entry 1 Rott Roland · CIK 0001952159 · CEO, Imaging 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,983 F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 33% will vest on September 1, 2025, 33% will vest on September 1, 2026, and 34% will vest on September 1, 2027, subject to certain conditions. F2 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. Read SEC document |
| August 03, 2024 Filed Aug 6, 2024 20:05 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | Tax withholdingCommon Stock, par value $0.01 per share | 1,630 | $83.44 | $136,007.20 |
DisclosureSEC source: 0001628280-24-035175 · wk-form4_1722974736.xml · nonDerivative · entry 1 Rott Roland · CIK 0001952159 · CEO, Imaging 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,199 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| April 01, 2024 Filed Apr 2, 2024 22:41 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | Tax withholdingCommon Stock, par value $0.01 per share | 837 | $90.91 | $76,091.67 |
DisclosureSEC source: 0001628280-24-014445 · wk-form4_1712097697.xml · nonDerivative · entry 1 Rott Roland · CIK 0001952159 · CEO, Ultrasound 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,829 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:54 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantEmployee Stock Option (right to buy) · Derivative | 11,886 | $0.00 Strike: $92.72 | $0.00 |
DisclosureSEC source: 0001628280-24-009082 · wk-form4_1709679280.xml · derivative · entry 5 Rott Roland · CIK 0001952159 · CEO, Ultrasound 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,886 Underlying: Common Stock, par value $0.01 per share · 11,886 shares Expires 2034-03-01 F5 · price: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 1, 2025, 33% will become exercisable on September 1, 2026, and 34% will become exercisable on September 1, 2027, subject to certain conditions. F5 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 1, 2025, 33% will become exercisable on September 1, 2026, and 34% will become exercisable on September 1, 2027, subject to certain conditions. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:54 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantCommon Stock, par value $0.01 per share | 4,179 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-009082 · wk-form4_1709679280.xml · nonDerivative · entry 4 Rott Roland · CIK 0001952159 · CEO, Ultrasound 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,666 F3 · shares: Award of restricted stock units with respect to GE HealthCare common stock, of which 33% will vest on September 1, 2025, 33% will vest on September 1, 2026, and 34% will vest on September 1, 2027, subject to certain conditions. F4 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:54 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | Tax withholdingCommon Stock, par value $0.01 per share | 2,169 | $91.28 | $197,986.32 |
DisclosureSEC source: 0001628280-24-009082 · wk-form4_1709679280.xml · nonDerivative · entry 3 Rott Roland · CIK 0001952159 · CEO, Ultrasound 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,487 F2 · shares: Withholding of shares of GE HealthCare common stock to satisfy tax withholding obligations in connection with the vesting of performance stock units previously reported by the reporting person in the Form 4 filed with the Securities and Exchange Commission on December 29, 2023. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:54 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | Tax withholdingCommon Stock, par value $0.01 per share | 1,457 | $91.28 | $132,994.96 |
DisclosureSEC source: 0001628280-24-009082 · wk-form4_1709679280.xml · nonDerivative · entry 2 Rott Roland · CIK 0001952159 · CEO, Ultrasound 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,656 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. ("GE HealthCare") common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:54 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | Tax withholdingCommon Stock, par value $0.01 per share | 929 | $91.28 | $84,799.12 |
DisclosureSEC source: 0001628280-24-009082 · wk-form4_1709679280.xml · nonDerivative · entry 1 Rott Roland · CIK 0001952159 · CEO, Ultrasound 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,113 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. ("GE HealthCare") common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| August 03, 2023 Filed Aug 7, 2023 20:06 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | Tax withholdingCommon Stock, par value $0.01 per share | 1,630 | $76.19 | $124,189.70 |
DisclosureSEC source: 0001628280-23-027763 · wk-form4_1691438781.xml · nonDerivative · entry 1 Rott Roland · CIK 0001952159 · CEO, Ultrasound 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,705 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| June 08, 2023 Filed Jun 12, 2023 20:06 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | SaleCommon Stock, par value $0.01 per share | 2,473 | $77.37 | $191,336.01 |
DisclosureSEC source: 0001628280-23-021856 · wk-form4_1686600346.xml · nonDerivative · entry 1 Rott Roland · CIK 0001952159 · CEO, Ultrasound 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,335 Read SEC document |
| April 01, 2023 Filed Apr 3, 2023 20:06 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | Tax withholdingCommon Stock, par value $0.01 per share | 837 | $82.12 | $68,734.44 |
DisclosureSEC source: 0001628280-23-010384 · wf-form4_168055239604902.xml · nonDerivative · entry 1 Rott Roland · CIK 0001952159 · CEO, Ultrasound 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,808 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| March 02, 2023 Filed Mar 4, 2023 00:53 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | Tax withholdingCommon Stock, par value $0.01 per share | 541 | $75.04 | $40,596.64 |
DisclosureSEC source: 0001628280-23-006430 · wf-form4_167789116476330.xml · nonDerivative · entry 3 Rott Roland · CIK 0001952159 · CEO, Ultrasound 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,645 F3 · shares: Withholding of shares of GE HealthCare common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| March 01, 2023 Filed Mar 4, 2023 00:53 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantEmployee Stock Option (right to buy) · Derivative | 11,578 | $0.00 Strike: $75.30 | $0.00 |
DisclosureSEC source: 0001628280-23-006430 · wf-form4_167789116476330.xml · derivative · entry 4 Rott Roland · CIK 0001952159 · CEO, Ultrasound 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,578 Underlying: Common Stock, par value $0.01 per share · 11,578 shares Expires 2033-03-01 F4 · price: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 1, 2024, 33% will become exercisable on September 1, 2025, and 34% will become exercisable on September 1, 2026. F4 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 1, 2024, 33% will become exercisable on September 1, 2025, and 34% will become exercisable on September 1, 2026. Read SEC document |
| March 01, 2023 Filed Mar 4, 2023 00:53 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | Tax withholdingCommon Stock, par value $0.01 per share | 928 | $75.30 | $69,878.40 |
DisclosureSEC source: 0001628280-23-006430 · wf-form4_167789116476330.xml · nonDerivative · entry 2 Rott Roland · CIK 0001952159 · CEO, Ultrasound 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,186 F3 · shares: Withholding of shares of GE HealthCare common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| March 01, 2023 Filed Mar 4, 2023 00:53 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantCommon Stock, par value $0.01 per share | 4,150 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-006430 · wf-form4_167789116476330.xml · nonDerivative · entry 1 Rott Roland · CIK 0001952159 · CEO, Ultrasound 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,114 F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 33% will vest on September 1, 2024, 33% will vest on September 1, 2025, and 34% will vest on September 1, 2026. F2 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. Read SEC document |
| February 09, 2023 Filed Dec 29, 2023 23:01 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantCommon Stock, par value $0.01 per share | 4,338 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-042948 · wk-form4_1703890907.xml · nonDerivative · entry 1 Rott Roland · CIK 0001952159 · CEO, Ultrasound 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,042 F1 · date: Inadvertently filed late due to an administrative error. F2 · shares: Performance stock units ("PSUs") granted on March 1, 2021 by General Electric Company ("GE") prior to the January 3, 2023 distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") to holders of GE common stock on a pro rata basis. The applicable performance criteria were satisfied and certified by GE's Management Development and Compensation Committee on February 9, 2023. Each PSU represents the right to receive, at settlement, one share of GE HealthCare common stock. The PSUs vest on March 1, 2024, subject to the reporting person's continued employment. F3 · balance_after: This direct ownership total reflects 1 fewer shares of common stock than were reported as directly held on the Form 4 filed by the reporting person on January 5, 2023 as a result of conversion mechanics involved in the Spin-Off. Read SEC document |
| February 01, 2023 Filed Feb 3, 2023 23:01 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantEmployee Stock Option (right to buy) · Derivative | 19,596 | Not disclosed Strike: $70.01 | Not disclosed |
DisclosureSEC source: 0001628280-23-002260 · wf-form4_167546523995287.xml · derivative · entry 2 Rott Roland · CIK 0001952159 · CEO, Ultrasound 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,596 Underlying: Common Stock, par value $0.01 per share · 19,596 shares Expires 2033-02-01 F4 · price: Award of an employee stock option with respect to GE HealthCare common stock, of which 50% will become exercisable on February 1, 2025 and 50% will become exercisable on February 1, 2026. F4 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock, of which 50% will become exercisable on February 1, 2025 and 50% will become exercisable on February 1, 2026. Read SEC document |
| February 01, 2023 Filed Feb 3, 2023 23:01 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantCommon Stock, par value $0.01 per share | 2,231 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-002260 · wf-form4_167546523995287.xml · nonDerivative · entry 1 Rott Roland · CIK 0001952159 · CEO, Ultrasound 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,964 F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 50% will vest on February 1, 2025 and 50% will vest on February 1, 2026. F2 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. F3 · balance_after: The reporting person has reported prior awards of restricted stock units in Table II of Form 4. The total reported in Column 5 includes 2,231 newly awarded restricted stock units, 20,488 previously reported restricted stock units, and 245 shares of common stock. Read SEC document |
| January 04, 2023 Filed Jan 6, 2023 01:40 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantRestricted Stock Units · Derivative | 5,828 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-23-001105 · doc4.xml · derivative · entry 18 Rott Roland · CIK 0001952159 · CEO, Ultrasound 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,828 Underlying: Common stock, par value $0.01 per share · 5,828 shares Expires not disclosed F5 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. F10 · derivative.exercise_date: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on March 1, 2024 and 50% will vest on March 1, 2025. F10 · derivative.expiration_date: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on March 1, 2024 and 50% will vest on March 1, 2025. Read SEC document |
| January 04, 2023 Filed Jan 6, 2023 01:40 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantRestricted Stock Units · Derivative | 3,347 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-23-001105 · doc4.xml · derivative · entry 17 Rott Roland · CIK 0001952159 · CEO, Ultrasound 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,347 Underlying: Common stock, par value $0.01 per share · 3,347 shares Expires not disclosed F5 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. F9 · derivative.exercise_date: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on April 1, 2023 and 50% will vest on April 1, 2024. F9 · derivative.expiration_date: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on April 1, 2023 and 50% will vest on April 1, 2024. Read SEC document |
| January 04, 2023 Filed Jan 6, 2023 01:40 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantRestricted Stock Units · Derivative | 3,713 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-23-001105 · doc4.xml · derivative · entry 16 Rott Roland · CIK 0001952159 · CEO, Ultrasound 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,713 Underlying: Common stock, par value $0.01 per share · 3,713 shares Expires not disclosed F5 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. F8 · derivative.exercise_date: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on March 1, 2023 and 50% will vest on March 1, 2024. F8 · derivative.expiration_date: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on March 1, 2023 and 50% will vest on March 1, 2024. Read SEC document |
| January 04, 2023 Filed Jan 6, 2023 01:40 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantRestricted Stock Units · Derivative | 6,519 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-23-001105 · doc4.xml · derivative · entry 15 Rott Roland · CIK 0001952159 · CEO, Ultrasound 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,519 Underlying: Common stock, par value $0.01 per share · 6,519 shares Expires not disclosed F5 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. F7 · derivative.exercise_date: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on August 3, 2023 and 50% will vest on August 3, 2024. F7 · derivative.expiration_date: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on August 3, 2023 and 50% will vest on August 3, 2024. Read SEC document |
| January 04, 2023 Filed Jan 6, 2023 01:40 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantRestricted Stock Units · Derivative | 1,081 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-23-001105 · doc4.xml · derivative · entry 14 Rott Roland · CIK 0001952159 · CEO, Ultrasound 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,081 Underlying: Common stock, par value $0.01 per share · 1,081 shares Expires not disclosed F5 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. F6 · derivative.exercise_date: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% will vest on March 2, 2023. F6 · derivative.expiration_date: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% will vest on March 2, 2023. Read SEC document |
| January 04, 2023 Filed Jan 6, 2023 01:40 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantEmployee Stock Option (right to buy) · Derivative | 8,536 | Not disclosed Strike: $75.24 | Not disclosed |
DisclosureSEC source: 0000899243-23-001105 · doc4.xml · derivative · entry 13 Rott Roland · CIK 0001952159 · CEO, Ultrasound 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,536 Underlying: Common stock, par value $0.01 per share · 8,536 shares Expires 2031-04-01 F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. F4 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will become exercisable on April 1, 2023 and 50% will become exercisable on April 1, 2024. Read SEC document |
| January 04, 2023 Filed Jan 6, 2023 01:40 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantEmployee Stock Option (right to buy) · Derivative | 7,214 | Not disclosed Strike: $63.51 | Not disclosed |
DisclosureSEC source: 0000899243-23-001105 · doc4.xml · derivative · entry 12 Rott Roland · CIK 0001952159 · CEO, Ultrasound 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,214 Underlying: Common stock, par value $0.01 per share · 7,214 shares Expires 2030-03-02 F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. F3 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% is exercisable immediately and 50% will become exercisable on March 2, 2023. Read SEC document |
| January 04, 2023 Filed Jan 6, 2023 01:40 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantEmployee Stock Option (right to buy) · Derivative | 1,614 | Not disclosed Strike: $51.67 | Not disclosed |
DisclosureSEC source: 0000899243-23-001105 · doc4.xml · derivative · entry 11 Rott Roland · CIK 0001952159 · CEO, Ultrasound 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,614 Underlying: Common stock, par value $0.01 per share · 1,614 shares Expires 2029-04-11 F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. F2 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% is fully exercisable immediately. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.